HBM Holdings Says Unit & Sichuan Kelun-Biotech Biopharmaceutical Entered License Agreement
Hbm Holdings Ltd 2142:
UNIT & SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL HAVE ENTERED INTO A LICENSE AGREEMENT
AGREEMENT TO LICENSE KELUN-BIOTECH TO USE UNIT'S PROPRIETARY FULLY H2L2 TRANSGENIC HARBOUR MICE ® PLATFORM